Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2

The current SARS-CoV-2 pandemic, along with the likelihood that new coronavirus strains will appear in the nearby future, highlights the urgent need to develop new effective antiviral agents. In this scenario, emerging host-targeting antivirals (HTAs), which act on host-cell factors essential for vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasquero, Selina, Gugliesi, Francesca, Griffante, Gloria, Dell’Oste, Valentina, Biolatti, Matteo, Albano, Camilla, Bajetto, Greta, Delbue, Serena, Signorini, Lucia, Dolci, Maria, Landolfo, Santo, De Andrea, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915624/
https://www.ncbi.nlm.nih.gov/pubmed/35288208
http://dx.doi.org/10.1016/j.antiviral.2022.105278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915624/
https://www.ncbi.nlm.nih.gov/pubmed/35288208
http://dx.doi.org/10.1016/j.antiviral.2022.105278

Ejemplares similares